Neither soft nor hard - pattern of development of new technology based firms in biotechnology

Technovation

Volumn 19, Issue 11, 1999, Pages 651-659

  Pfirrmann, Oliver ^a  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

PRODUCT DEVELOPMENT; SUSTAINABLE DEVELOPMENT;

FIRM GROWTH;

BIOTECHNOLOGY;

EID: 0033341737     PISSN: 01664972     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-4972(99)00080-2     Document Type: Article

References (18)

1. Audretsch D., Feldman M. Innovative clusters and the industry life cycle. Review of Industrial Organization. 11:1996;253-273.
2. Bollinger L., Hope A., Utterback J.M. A review of literature and hypotheses on new technology based firms. Research Policy. 12:1983;1-14.
3. Bullock M. Academic Enterprise, Industrial Innovation, and the Development of High Technology Financing in the United States. 1983;Brand Brothers and Co, London.
4. Cheesborough H., Teece D. When is the virtual model virtuous? Harvard Business Review. 74:1996;65-71.
5. Christensen J.F. Asset profiles for technological innovation. Research Policy. 24:1995;727-745.
6. Greis N.P., Dibner M.D., Bean A.S. External partnering as a response to innovation barriers and global competition in biotechnology. Research Policy. 24:1995;609-630.
7. Haug P., Ness P. Technological infrastructure and regional economic development of biotechnology firms. Technovation. 12:1992;423-432.
8. Krugman P. Geography and Trade. 1991;MIT Press, Cambridge, MA.
9. Mowery D., Rosenberg N. The influence of market demand upon innovation: a critical review of some recent empirical studies. Research Policy. 8:1979;102-153.
10. OTA Biotechnology in Global Economy. 1991;Congress of the United States, Washington, DC.
11. Penrose E. Theory of the Growth of the Firm. 1959;Blackwell, Oxford.
12. Pisano G. The governance of innovation: vertical integration and collaborative arrangements in the biotechnology industry. Research Policy. 20:1990;237-249.
13. Romer P.M. Endogenous technological change. Journal of Political Economy. 98:1990;71-102.
14. Schitag, Ernst & Young, 1998. Erster Deutscher Biotechnologie Report, Mai 1998. Schitag, Ernst & Young, Stuttgart/Mannheim.
15. Senker J. National systems of innovation, organizational learning and industrial biotechnology. Technovation. 16:1996;219-229.
16. Werth B. The Billion Dollar Molecule: One Company's Quest for the Perfect Drug. 1994;Simon and Schuster, New York.
17. Zucker L., Darby M., Brewer M. Intellectual human capital and the birth of US biotechnology enterprises. American Economic Review. 40:1997;502-513.
18. Zucker L.G., Darby M. Star scientists and institutional transformation: patterns of invention and innovation in the formation of the biotechnology industry. Proceedings of the National Academy of Science. 93:1996;12709-12716.